Precision Biosensor Inc
KOSDAQ:335810
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Catella AB
STO:CAT B
|
SE |
Precision Biosensor Inc
Net Income (Common)
Precision Biosensor Inc
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
P
|
Precision Biosensor Inc
KOSDAQ:335810
|
Net Income (Common)
-₩7.3B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-78%
|
CAGR 10-Years
N/A
|
|
|
Suheung Co Ltd
KRX:008490
|
Net Income (Common)
₩43.5B
|
CAGR 3-Years
9%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
7%
|
|
|
SD Biosensor Inc
KRX:137310
|
Net Income (Common)
-₩98.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
B
|
BioPlus Co Ltd
KOSDAQ:099430
|
Net Income (Common)
₩14.2B
|
CAGR 3-Years
10%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
H
|
HLB Inc
KOSDAQ:028300
|
Net Income (Common)
-₩220.5B
|
CAGR 3-Years
-41%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
T
|
T&L Co Ltd
KOSDAQ:340570
|
Net Income (Common)
₩46.4B
|
CAGR 3-Years
33%
|
CAGR 5-Years
45%
|
CAGR 10-Years
N/A
|
|
Precision Biosensor Inc
Glance View
Precision Biosensor, Inc. develops in-vitro diagnostics technology that provides advanced diagnostic solutions. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2020-12-22. The firm's main products include testers and cartridges. The testers are portable immunoassay diagnostic devices for on-site diagnosis that uses colorimetric and time-resolved fluorescence to check acute heart disease, metabolism, and inflammatory diseases. The cartridges are used in gold absorption and time-resolved fluorescence analysis diagnostic equipment, and can check acute heart disease, metabolism, and inflammatory diseases. The firm sells its products in domestic and overseas markets such as Europe, China, the Middle East, and Southeast Asia.
See Also
What is Precision Biosensor Inc's Net Income (Common)?
Net Income (Common)
-7.3B
KRW
Based on the financial report for Dec 31, 2024, Precision Biosensor Inc's Net Income (Common) amounts to -7.3B KRW.
What is Precision Biosensor Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-78%
Over the last year, the Net Income (Common) growth was -63%. The average annual Net Income (Common) growth rates for Precision Biosensor Inc have been -21% over the past three years , -78% over the past five years .
